Elekta to deploy MEG technology in French hospital

Elekta has signed a contract to deliver Elekta Neuromag, the equipment for non-invasive registration of nerve cell activity using magnetoencephalography (MEG) technology to the new Le Commissariat à l’Energie Atomique (CEA) facility - NeuroSpin in Saclay, France, one of the largest research sites for brain imaging in Europe.

The delivery of Elekta Neuromag is part of a collaboration contract signed between three parties: CEA, L’Institut National de la Santé et de la Recherche Médicale (INSERM), both French state-owned research entities with scientific, technical and industrial activity; and Elekta Neuromag Oy, part of the Elekta Group, the Stockholm, Sweden-based company said.

The MEG system is scheduled to be installed during spring of 2008 at NeuroSpin, which will host up to 150 research scientists and engineers from CEA and INSERM with a number of visiting groups, according to Elekta.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.